Vaptan Therapy
Vaptan Therapy is a pharmacological treatment modality that belongs to the class of targeted antidiuretic hormone antagonists, specifically characterized by its selective inhibition of vasopressin V2 receptors in the renal collecting ducts to promote aquaresis in patients with hyponatremia associated with ascites.
16
Publications
619
Citations
56
Authors
41
Institutions
Publications per year
2017–2026
5
Variants
Vasopressin Receptor Antagonist Therapy
Parents
16
Therapeutic Advances in Endocrinology and Metabolism · 2012 · 112 citations
Robert Gianotti, Andrés Cárdenas · Gastroenterology report · 2014 · 44 citations · Full text
Medicine, Nephrology, Physiology +16
Pere Ginès, Florence Wong, Hugh Watson et al. · Alimentary Pharmacology & Therapeutics · 2010 · 43 citations
1–5 of 16
56
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 56
41
University of Bari Aldo Moro
Bari, Italy
2 h-index
7 publications
138 citations

Beth Israel Deaconess Medical Center
Boston, United States
1 h-index
2 publications
88 citations
Allen Hospital
Waterloo, United States
1 h-index
1 publications
22 citations
Université Paris Cité
Paris, France
1 h-index
1 publications
17 citations
Metabolism and Renal Physiology
Paris, France
1 h-index
1 publications
17 citations
Centre de Recherche des Cordeliers
Paris, France
1 h-index
1 publications
17 citations
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
Madrid, Spain
1 h-index
1 publications
43 citations

Centre Hospitalier Universitaire de Grenoble
Grenoble, France
1 h-index
1 publications
43 citations
1–8 of 41
1 publications · 27 citations
1
h-index
CJASN · 1 publications · 154 citations
1
h-index
1 publications · 11 citations
1
h-index
1 publications · 43 citations
1
h-index
1 publications · 30 citations
1
h-index
1–5